Molecular Medicine

molecular medicineThe Molecular Medicine Residency track within the Categorical Medicine Residency is designed for individuals who are interested in pursuing a career that emphasizes bench research in combination with the practice of medicine. The overarching goal of the program is to train the next generation of transformative laboratory-based physician-scientists.

The Molecular Medicine Residency provides specialized, individualized attention to each participant’s development as a bench scientist while maintaining the same broad and intensive exposure to clinical medicine that is enjoyed by all UCSF categorical internal medicine residents. Admission to the program is accompanied by a guaranteed subspecialty fellowship position within the Department of Medicine, contingent upon satisfactory completion of residency training. Successful applicants demonstrate potential for excellence in both clinical care and laboratory research, and will have completed a successful MD/PhD program or an in-depth research experience of at least one year.

Curriculum

Molecular Medicine Residents receive personal mentoring in selecting their area of research and choosing laboratories that may be of interest to them for training. They also meet regularly as a group for career guidance seminars and for scientific discussions in a relaxed, informal setting, and attend an annual dinner designed to facilitate interaction among members of the Department’s College of Bench Scientists. Dedicated time for scholarly activity is provided during the R2 year (and R3 year, if applicable). During the R2 year, Molecular Medicine Residents travel to the annual 3-day research retreat of the Biomedical Sciences Program in Lake Tahoe, California, where they can learn more about the rich scientific opportunities at UCSF and an have opportunity to fully immerse themselves in basic/translational science. Molecular Medicine Residents also participate in conferences of the UCSF Molecular Medicine Consult Service, which is designed to promote scientific inquiry among all residents. This service endeavors to apply state-of-the-art tools toward a better understanding of the molecular pathophysiology of disease. Historically, the majority of Molecular Medicine Residents have, pending approval from the Categorical Residency Program Director, opted to short-track into the ABIM Research Pathway.

Current Molecular Medicine Residents

Year

Name and Degree(s)

Degree Granting Institution

R3 2017

Kelly Fitzgerald, MD

University of California, Irvine

R3 2017

Meghan Jobson, MD PhD

University of North Carolina

R3 2017

Lowell Nicholson, MD

Duke University

R3 2017

Noa Simchoni, MD PhD

Icahn School of Medicine at Mt Sinai

R3 2017

Noah Younger, MD PhD

University of California, San Francisco

R2 2018

Christina Homer, MD PhD

University of California, San Francisco

R2 2018

Sarah Hsu, MD PhD

University of Pennsylvania

R2 2018

John Huizar, MD

University of California, San Francisco

R2 2018

Jerry Lee, MD

Duke University

R2 2018

Worawan Limpitikul, MD PhD

Johns Hopkins University

R2 2018

T. Richard Parenteau, MD PhD

University of California, San Francisco

R2 2018

Natasha Spottiswoode, MD PhD

Columbia University

R2 2018

Joshua Schoenfeld, MD PhD

University of Iowa

R2 2018

Travis Zack, MD PhD

Harvard University

R1 2019

Ryan Chang, MD PhD

University of California, San Francisco

R1 2019

Mai Dao, MD

Harvard University

R1 2019

Charlotte Hurabielle-Claverie, MD PhD

Faculte de Medecine Paris Descartes

R1 2019

Anjali Jacob, MD PhD

Boston University

R1 2019

Matthew Jones, MD PhD

University of Chicago

R1 2019

Vipul Kumar, MD PhD

Harvard University

R1 2019

Quinlan Siervers, MD PhD

Harvard University

R1 2019

Jeremiah Wala, MD PhD

Harvard University

R1 2019

Robert Weber, MD PhD

University of California, San Francisco

R1 2019

Andrew Lechner, MD PhD

University of California, San Francisco

Recent Participants

Degree Granting Institution Name Subspecialty

2014 Harvard

Vincent Auyeung, MD, PhD

Pulmonary Disease and Critical Care Medicine, UCSF

2014 UCSF

Alan Baik, MD

Cardiology, UCSF

2014 UCSF

Jonathan Chou, MD, PhD

Hematology and Oncology, UCSF

2014 University of Washington

Joseph Hiatt, MD, PhD

Hematology and Oncology, University of Washington

2015 University of Pennsylvania

Chukwuka Didigu, MD, PhD

Hematology and Oncology, UCSF

2015 Harvard

Laura Huppert, MD,

Hematology and Oncology, UCSF

2015 Washington University

Hailyn Nielsen, MD, PhD

Rheumatology, UCSF

2015 University of Chicago

Vaibhav Upadhyay, MD, PhD

Pulmonary Disease and Critical Care Medicine, UCSF

2016 Yale

Nancy Allen, MD, PhD

Pulmonary Disease and Critical Care Medicine, UCSF

2016 Columbia

Stewart Cao, MD, PhD

Gastroenterology, Washington University, St. Louis

2016 University of Michigan

Cailin Collins, MD, PhD

Hematology and Oncology, Stanford University

2016 Baylor

Andrew Folick, MD, PhD

Endocrinology, UCSF

2016 Johns Hopkins

Bridget Keenan, MD, PhD

Hematology and Oncology, UCSF

2016 Icahn School of Medicine at Mount Sinai

Arielle Klepper, MD, PhD

Chief Resident, Internal Medicine, UCSF

2016 Pennsylvania State University College of Medicine

Michelle Matzko, MD, PhD

Infectious Diseases, MGH/BWH

2016 UCSF

Alex Mohapatra, MD, PhD

Pulmonary Disease and Critical Care Medicine, UCSF

2016 Baylor

Kapil Saxena, MD

Hematology and Oncology, MDACC

2017 New York University

Adam Blaisdell, MD, PhD

Gastroenterology, UCSF

2017 Univeristy of Pittsburgh

John Demko, MD

Nephrology, UCSF

2017 Yale

Brendan Huang, MD, PhD

Pulmonary Disease and Critical Care Medicine, UCLA

2017 Cornell

Corynn Kasap, MD, PhD

Hematology and Oncology, UCSF

2017 Cornell

Maxime Kinet, MD, PhD

Rheumatology, UCSF

Application Logistics

Upon receipt of the electronic Residency Application from ERAS, the Residency Admissions Committee selects applicants for interview at UCSF. Applicants invited for an interview are then asked if they wish to be considered for the Molecular Medicine Residency. A separate selection committee reviews applicants and issues invitations to remain an extra day after the Categorical Residency application day to interview specifically for the Molecular Medicine Residency.

As stated above, acceptance into the Molecular Medicine Residency includes a commitment of a fellowship position in a specialty of choice. A Molecular Medicine Residency participant, however, may also choose not to specify a particular specialty and, instead, wait to apply after exploring different opportunities during residency.

The UCSF Molecular Medicine Residency Program is fully committed to enhancing diversity at UCSF.
Applications from women and under-represented ethnic/cultural groups are strongly encouraged.

Neil P. Shah, MD PhD
Director, UCSF Molecular Medicine Residency Program

 

Contact Us

Additional questions may be addressed to Vivian Robinson.

Vivian Robinson
415-476-3373
[email protected]

 

Thank you for your interest in the UCSF Molecular Medicine Residency Program.